目的观察黄连解毒汤联合腰俞八阵在混合痔术后创面修复中的应用效果。
方法将2021年10月至2022年10月浙江省丽水市人民医院收治的70例混合痔手术患者按随机数字表法随机分为2组。对照组35例予以常规治疗,研究组35例予以黄连解毒汤联合腰俞八阵治疗。评价2组的临床疗效、创缘水肿程度、疼痛程度,对比2组治疗前、治疗后的创面出血及分泌物评分,比较2组的创面愈合时间及治疗前后的血小板源性生长因子(PDFG)、血管内皮生长因子(VEGF)、碱性成纤维生长因子(bFGF)水平。
结果研究组的临床治疗总有效率为94.3%,高于对照组的74.3%( χ 2=5.286, P<0.05);治疗后7 d,研究组的疼痛及创缘水肿程度较对照组改善( Z=4.523, P<0.05);治疗后7 d,研究组的创面出血及分泌物评分分别为(0.58±0.12)分和(0.82±0.17)分,较对照组的(0.94±0.26)分、(1.13±0.23)分降低( t=7.438,6.412, P<0.05);研究组的创面愈合时间为(23±5)d,低于对照组的(34±6)d( t=8.410, P<0.05);治疗后7 d,研究组PDFG、VEGF、bFGF水平分别为(57±6)ng/L、(115±19)ng/L、(67±9)ng/L,较对照组升高[(45±5)ng/L、(104±17)ng/L、(60±10)ng/L]( t=9.330,2.545,2.966, P<0.05)。
结论黄连解毒汤联合腰俞八阵在混合痔术后创面修复中应用效果显著,可有效减轻患者的创面水肿、疼痛程度,减少创面出血及分泌物,有助于促进创面愈合。
ObjectiveTo observe the clinical efficacy of Huanglian Jiedu Decoction combined with Yaoshu Bazhen in the treatment of postoperative would repair in mixed hemorrhoid.
MethodsFrom October 2021 to October 2022, a total of 70 patients in Lishui People ′s Hospital undergoing mixed hemorrhoid surgery were randomly divided into a control group ( n=35) and a study group ( n=35). The control group was treated with conventional therapy, while the study group was treated with Huanglian Jiedu Decoction combined with Yaoshu Bazhen. The clinical efficacy, wound edge edema and pain severity of the two groups were evaluated. Before and after the treatment, the scores of wound bleeding and secretion, wound healing time and the levels of platelet-derived growth factor (PDFG), vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF) were compared between the two groups.
ResultsThe total effective rate of clinical treatment in the study group was 94.3%, which was higher than the 74.3% of the control group ( χ 2=5.286, P<0.05). After 7 days of treatment, the pain and wound margin edema in the study group were significantly reduced compared to the control group ( Z=4.523; P<0.05). After 7 days of treatment, the wound bleeding and secretion scores of the study group were (0.58±0.12) points and (0.82±0.17) points, respectively, which were significantly lower than those of the control group (0.94±0.26) points and (1.13±0.23) points ( t=7.438, 6.412, P<0.05). The wound healing time of the study group (23±5) days was shorter than that of the control group (34±6) days ( t=8.410 , P<0.05). Additionally, the levels of PDFG, VEGF, and bFGF in the study group were significantly higher than those in the control group [(57±6) ng/L vs. (45±5) ng/L; (115±19) ng/L vs. (104±17) ng/L; (67±9) ng/L vs. (60±10) ng/L; t=9.330, 2.545, 2.966; P<0.05].
ConclusionHuanglian Jiedu Decoction combined with Yaoshu Bazhen significantly improves wound healing after mixed hemorrhoid surgery by reducing wound edema, pain, wound bleeding and secretions.
季奕秧,吴婧,程涛,等. 黄连解毒汤联合腰俞八阵在混合痔术后创面修复中的应用[J]. 中国药物与临床,2025,25(06):377-381.
DOI:10.11655/zgywylc2025.06.007组别 | 例数 | 性别 | 年龄/(岁,
|
病程/(年,
|
|||
---|---|---|---|---|---|---|---|
男性 | 女性 | ||||||
例数 | % | 例数 | % | ||||
研究组 | 35 | 18 | 51.4 | 17 | 48.6 | 46±6 | 5.3±1.4 |
对照组 | 35 | 20 | 57.1 | 15 | 42.9 | 45±6 | 5.8±1.4 |
t/ χ 2值 | 0.230 | 0.704 | 1.460 | ||||
P值 | 0.631 | 0.484 | 0.148 |
组别 | 例数 | 痊愈 | 显效 | 有效 | 无效 | 总有效 | |||||
---|---|---|---|---|---|---|---|---|---|---|---|
例数 | % | 例数 | % | 例数 | % | 例数 | % | 例数 | % | ||
研究组 | 35 | 15 | 42.9 | 12 | 34.3 | 6 | 17.1 | 2 | 5.7 | 33 | 94.3 |
对照组 | 35 | 12 | 34.3 | 10 | 28.6 | 4 | 11.4 | 9 | 25.7 | 26 | 74.3 |
组别 | 例数 | 无水肿 | 轻度水肿 | 中度水肿 | 重度水肿 | ||||
---|---|---|---|---|---|---|---|---|---|
例数 | % | 例数 | % | 例数 | % | 例数 | % | ||
研究组 | 35 | 15 | 42.9 | 14 | 40.0 | 6 | 17.1 | 0 | 0 |
对照组 | 35 | 10 | 28.6 | 10 | 28.6 | 12 | 34.3 | 3 | 8.6 |
组别 | 例数 | 无疼痛 | 轻度疼痛 | 中度疼痛 | 重度疼痛 | ||||
---|---|---|---|---|---|---|---|---|---|
例数 | % | 例数 | % | 例数 | % | 例数 | % | ||
研究组 | 35 | 17 | 48.6 | 15 | 42.9 | 3 | 8.6 | 0 | 0 |
对照组 | 35 | 12 | 34.3 | 11 | 31.4 | 8 | 22.9 | 4 | 11.4 |
组别 | 例数 | 创面出血评分/分 | 创面分泌物评分/分 | 创面愈合时间/d | ||
---|---|---|---|---|---|---|
治疗前 | 治疗后 | 治疗前 | 治疗后 | |||
研究组 | 35 | 2.42±0.38 | 0.58±0.12 a | 2.28±0.49 | 0.82±0.17 a | 23±5 |
对照组 | 35 | 2.33±0.54 | 0.94±0.26 a | 2.12±0.35 | 1.13±0.23 a | 34±6 |
t值 | 0.806 | 7.438 | 1.572 | 6.412 | 8.410 | |
P值 | 0.423 | <0.01 | 0.121 | <0.01 | <0.01 |
注: a与同组治疗前比较 P<0.05。
组别 | 例数 | PDFG | VEGF | bFGF | |||
---|---|---|---|---|---|---|---|
治疗前 | 治疗后 | 治疗前 | 治疗后 | 治疗前 | 治疗后 | ||
研究组 | 35 | 41±7 | 57±6 a | 92±19 | 115±19 a | 52±10 | 67±9 a |
对照组 | 35 | 40±8 | 45±5 a | 90±20 | 104±17 a | 52±11 | 60±10 a |
t值 | 0.516 | 9.330 | 0.442 | 2.545 | 0.281 | 2.966 | |
P值 | 0.608 | <0.01 | 0.660 | 0.013 | 0.779 | 0.004 |
注:PDFG,血小板源性生长因子;VEGF,血管内皮生长因子;bFGF,碱性成纤维生长因子。
季奕秧:设计研究方案,实施研究过程,论文撰写;吴婧:提出研究思路、论文修改及审核;程涛:实施研究过程,分析实验数据;潘善余:统计学分析,论文修改

你好,我可以帮助您更好的了解本文,请向我提问您关注的问题。